Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
PROGAS
1 other identifier
interventional
200
1 country
1
Brief Summary
For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2021
CompletedFirst Submitted
Initial submission to the registry
June 4, 2021
CompletedFirst Posted
Study publicly available on registry
August 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
December 22, 2023
December 1, 2023
9.6 years
June 4, 2021
December 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in genital sensitivity pattern at 24 months
Mapping of pressure thresholds of Semmes-Weinstein monofilaments in pre-defined areas of the neo-genital area
Baseline function test, followed by reassessment at 3, 6, 9, 12, 15, 18, 21 and 24 months of follow-up
Secondary Outcomes (12)
Change in postoperative sexual function
Baseline questionnaire, followed by reassessment at 12 and 24 months of follow-up
Change in self-assessment of genital anatomy and genital sensitivity
Baseline questionnaire, followed by reassessment at 3, 6, 9, 12, 15, 18, 21 and 24 months of follow-up
Change in voiding function
Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Change in urinary continence
Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Change in maximum flow rate
Uroflowmetry at baseline, followed by uroflowmetry at 3, 6, 12 and 24 months of follow-up
- +7 more secondary outcomes
Study Arms (1)
Genital sensation and sexual functioning assessment
EXPERIMENTALGenital sensation testing with clinical assessment and self-examination questionnaire. Sexual functioning testing with questionnaires.
Interventions
Semmes-Weinstein test for the assessment of genital sensation Battery of questionnaires assessing sexual function, voiding function, quality of life and patient satisfaction
Eligibility Criteria
You may qualify if:
- Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations
- Patient age ≥ 18 years
- Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery
- Fit for operation, based on the surgeon's expert opinion
- Patient is able and willing to attend the follow-up consultations
You may not qualify if:
- Absence of signed written informed consent and thus a patient unwilling to participate.
- Patient age \< 18 years
- Cisgender patients
- Patients unfit for operation
- Patient declares that it will be impossible for him to attend the follow-up consultations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Ghent
Ghent, East-Flanders, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2021
First Posted
August 6, 2021
Study Start
May 27, 2021
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
December 22, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share